Sorafenib - Wikipedia
https://en.wikipedia.org/wiki/Sorafenib
WebSorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
DA: 12 PA: 21 MOZ Rank: 77